BCNU (NSC-409962) in the treatment of advanced Hodgkin's disease, lymphosarcoma, and reticulum cell sarcoma.
作者信息
Rege V B, Owens A H
出版信息
Cancer Chemother Rep. 1974 May-Jun;58(3):383-92.
PMID:4601668
Abstract
摘要
相似文献
1
BCNU (NSC-409962) in the treatment of advanced Hodgkin's disease, lymphosarcoma, and reticulum cell sarcoma.
Cancer Chemother Rep. 1974 May-Jun;58(3):383-92.
2
Toxicity study of BCNU (NSC-409962) given orally.口服卡氮芥（NSC-409962）的毒性研究。
Cancer Chemother Rep. 1974 May-Jun;58(3):407-11.
3
4
Primary treatment of disseminated Hodgkin's disease with BCNU alone and in combination with vincristine, procarbazine, and prednisone.
Cancer Treat Rep. 1977 Aug;61(5):789-95.
5
Treatment of Hodgkin's disease and other cancers with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).
Cancer Chemother Rep. 1971 Dec;55(5):599-606.
6
7
[On the therapy of lymphogranuloma. CCNU (1(2-chlorethyl)-3-cyclohexyl-1-nitrosourea) and BCNU (1,3-bis(2-chlorethyl)-1-nitrosourea) as well as BCNU combinations in Hodgkin's lymphogranuloma, stage 3 and 4].
Schweiz Med Wochenschr. 1972 Oct 28;102(43):1546-51.
8
Development of four-drug BCNU combination chemotherapy regimens.四种药物联合卡氮芥化疗方案的研发。
Cancer. 1973 Aug;32(2):277-85. doi: 10.1002/1097-0142(197308)32:2<277::aid-cncr2820320201>3.0.co;2-w.
9
Evaluation of uracil mustard in children with Hodgkin's disease, lymphosarcoma, and soft tissue sarcoma.
J Clin Pharmacol New Drugs. 1972 Apr;12(4):169-73. doi: 10.1002/j.1552-4604.1972.tb00046.x.
10
Comparison of methyl-CCNU and CCNU in patients with advanced forms of Hodgkin's disease, lymphosarcoma nad reticulum cell sarcoma.甲环亚硝脲与环己亚硝脲治疗晚期霍奇金病、淋巴肉瘤和网状细胞肉瘤患者的比较。
Cancer. 1978 May;41(5):1658-63. doi: 10.1002/1097-0142(197805)41:5<1658::aid-cncr2820410502>3.0.co;2-i.
引用本文的文献
1
Antineoplastic drugs in 1990. A review (Part II).1990年的抗肿瘤药物。综述（第二部分）。
Drugs. 1990 May;39(5):652-73. doi: 10.2165/00003495-199039050-00003.
Zotero 插件